First approved in 2019 to lower blood sugar levels in T2D, Rybelsus may help in both primary prevention (preventing first-time heart problems) and secondary prevention (reducing the risk of another event in those who've already had one) of MACE
That is one reason protein has become such a powerful selling point in the GLP-1 era
doi:10.1016/j.peh.2015.06.001 Breindahl, T., Evans-Brown, M., Hindersson, P., McVeigh, J., Bellis, M., Stensballe, A
This holistic approach is itself clinically supported: Personalized, Balanced Nutrition: The medication makes it easier to adhere to a healthy, reduced-calorie diet by naturally diminishing hunger, but structured nutritional guidance ensures its sustainable and nutritionally complete
These events most often occur during or following an episode of metabolic decompensation